SHENZHEN PRO HITU MEDICAL CO., LTD.

  • Company History
Company History
2020
  • 2020

    Received the CFDA certificate for PRO5G, a therapeutic ultrasound device for gynecological diseases

    Received funding from the major future industry project "Non-Invasive Focused Ultrasound Therapy for Malignant Tumors (Pancreatic Cancer)" in Shenzhen

    Established the Guangdong Provincial Ultrasonic Cavitation Research Technology Center

2017-2019
  • 2019

    Received the CFDA certificate for PRO5G, a therapeutic ultrasound device for gynecological diseases

    Received funding from the major future industry project "Non-Invasive Focused Ultrasound Therapy for Malignant Tumors (Pancreatic Cancer)" in Shenzhen

    Established the Guangdong Provincial Ultrasonic Cavitation Research Technology Center

  • 2018

    Received the CFDA certificate for the focused ultrasound therapy system PRO300 in September

    Achieved a breakthrough in ultrasonic cavitation technology research, emulsifying in vivo/in vitro tissues for the first time in China

    Passed the acceptance of the future industry project by the Economic and Information Technology Committee

    Passed the acceptance of the start-up funding project by the Municipal Science and Technology Innovation Committee

    The Technology Research on Mobile Non-Invasive Treatment of Hydatid Disease was approved for the Bank-Government-Enterprise Program by the Municipal Science and Technology Innovation Committee

  • 2017

    Officially changed the name to SHENZHEN PRO HITU MEDICAL CO., LTD.

    Ranked in the top 10 of the annual "Deloitte - Shenzhen Technology Fast 20"

    Received the honor of "Innovation of the Times - Influential Enterprise of the Year" from the China Finance Summit

    Created two annual "Shenzhen Enterprise Innovation Records"

    Received the "2017 Responsible Brand Award" at the 7th China Charity Festival

    Obtained the intellectual property standard implementation system certification

    Obtained 7 invention patents and 21 utility model patents

2012-2016
  • 2016

    Launched research and development of new products and started to get involved in the treatment of malignant tumors and chronic pain

    Received the "Product Development Innovation Project Award" from the 15th Shenzhen Enterprise Innovation Record Committee

    Became one of the units that set the industry standard for focused ultrasound therapy

  • 2015

    Won the first prize in the enterprise category at the finals of the China (Shenzhen) Innovation and Entrepreneurship Competition

    Received the "Excellent IPR Investment/ Financing Project" award from the Shenzhen Intellectual Property Administration

    Exceeded in sales in the overseas market and received the GMP certificate and product registration certificate from MFDS in South Korea

    Received the Best Clinical Medicine Transformation Award at the China Medical Industry Development and Innovation Awards

  • 2014

    Cooperated with the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences

    Obtained the national high-tech enterprise certificate

    Obtained the software enterprise certification

  • 2012

    Participated in the first registration review in Beijing

    Became the first company in China to obtain the CFDA registration certificate in gynecology (treatment)

    获得此证

    Obtained the 13485 medical quality system certificate

2003-2010
  • 2010

    Completed the first clinical trial in the Department of Ultrasound of Xijing Hospital of Xi'an Fourth Military Medical University

    Completed the national-standard clinical trial

  • 2006

    Conducted clinical trials on rabbits and pigs with the products developed by the company

    Developed the first-generation focused ultrasound system for the treatment of uterine fibroids

    Completed type tests and pre-clinical trials

  • 2003

    Shenzhen Pro Huiren Medical Technology Co., Ltd. was established